Heart failure and COPD: time to SHIFT?

Int J Cardiol. 2014 Mar 15;172(2):293-4. doi: 10.1016/j.ijcard.2013.12.285. Epub 2014 Jan 10.

Authors

Sandra Sanders-van Wijk¹, Vanessa van Empel¹, Christian Knackstedt¹, Hans-Peter Brunner-La Rocca²

Affiliations

¹ Department of Cardiology, Maastricht University Medical Centre, CARIM, Maastricht, The Netherlands.
² Department of Cardiology, Maastricht University Medical Centre, CARIM, Maastricht, The Netherlands. Electronic address: hp.brunnerlarocca@mumc.nl.

PMID: 24452222
DOI: 10.1016/j.ijcard.2013.12.285

No abstract available

Keywords: Beta-blocker; COPD; Heart failure; Ivabradine.

Publication types

Editorial
Comment

MeSH terms

Adrenergic beta-Antagonists / administration & dosage*
Benzazepines / administration & dosage*
Female
Heart Failure, Systolic / drug therapy*
Heart Failure, Systolic / mortality*
Heart Rate / drug effects*
Humans
Male
Pulmonary Disease, Chronic Obstructive / mortality*

Substances

Adrenergic beta-Antagonists
Benzazepines